Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ICU MedicalSTU:IC7 80 Interest Coverage is 3.26 as of Jun. 2026, which is 96% below its 10-year median of 77.34. GuruFocus rates STU:IC7 with a GF Score™ of 80/100 and a GF Value™ of €105.79 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 466 Medical Devices & Instruments companies, ICU Medical ranks worse than 90.77% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. ICU Medical's
Operating Income
for the
three
months ended in Jun. 2026 was €52 Mil. ICU Medical's Interest Expense for the
three
months ended in Jun. 2026 was €-16 Mil.
ICU Medical's interest coverage for the quarter that ended in Jun. 2026 was 3.26.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for ICU Medical's Interest Coverage or its related term are showing as below:
STU:IC7'
s Interest Coverage Range Over the Past 10 Years
Min: 0.47 Med: 77.34 Max: 839.13
Current: 1.75
STU:IC7's Interest Coverage is ranked worse than 90.77% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 16.545
vs STU:IC7: 1.75
ICU Medical (STU:IC7) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
ICU Medical Interest Coverage Related Terms
ICU Medical Interest Coverage Historical Data
* Premium members only.
The historical data trend for ICU Medical's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
STU:IC7 vs NVST, MMSI, MMED: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, ICU Medical's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICU Medical Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's Interest Coverage distribution charts can be found below:
* The bar in red indicates where ICU Medical's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Medical (STU:IC7) has a Interest Coverage of 3.26 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on ICU Medical and its competitors. This is 96% below median its historical median of 77.34. Over the past decade, ICU Medical's Interest Coverage has ranged from 0.47 to 839.13. According to the industry distribution chart, ICU Medical ranks #423 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 90.8%.
Is ICU Medical's Interest Coverage too high?
ICU Medical's current Interest Coverage of 3.26 is 96% below median its 10-year median of 77.34. Over the past 10 years, this metric has ranged from a low of 0.47 to a high of 839.13. The Medical Devices & Instruments industry median Interest Coverage is 16.55. ICU Medical's value of 3.26 is 80.3% below this industry median. Based on the distribution chart, ICU Medical ranks #423 out of 466 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, ICU Medical has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ICU Medical's Interest Coverage compare to NVST and MMSI?
According to the Medical Devices & Instruments industry distribution chart, ICU Medical ranks #423 out of 466 companies for Interest Coverage. This places ICU Medical in the lower half of its industry. The industry median Interest Coverage is 16.55. ICU Medical's value of 3.26 is 80.3% below this benchmark. Historically, ICU Medical's own Interest Coverage has ranged from 0.47 to 839.13 over the past decade. While the company's 10-year median is 77.34 vs. the industry median of 16.55, ICU Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.55, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ICU Medical's current Interest Coverage of 3.26 is 80.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on ICU Medical and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ICU Medical's current Interest Coverage is 3.26, which is 96% below median its own 10-year median of 77.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICU Medical stock overvalued right now?
Based on GuruFocus' analysis, ICU Medical (STU:IC7) is currently considered Significantly Overvalued. The stock's GF Value™ is €105.79, compared to a current price of €158.00 — trading 49.4% above its estimated fair value. The current Interest Coverage is 3.26, which is 96% below median its 10-year median of 77.34 and 80.3% below the Medical Devices & Instruments industry median of 16.55. ICU Medical's overall GF Score™ is 80/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For ICU Medical (STU:IC7), the current Interest Coverage is 3.26 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ICU Medical (STU:IC7) Overvalued in 2026?
Based on GuruFocus' analysis, ICU Medical stock appears to be overvalued.
The current stock price of €158.00 is trading 49.4% above its estimated GF Value™ of €105.79.
GuruFocus considers ICU Medical to be Significantly Overvalued.
Key valuation signals for STU:IC7:
Interest Coverage: 3.26 (96% below median its 10-year median of 77.34)
GF Value™: €105.79 vs. price of €158.00 (49.4% above fair value)
Industry Position: 80.3% below the Medical Devices & Instruments median (#423 of 466)
No single metric tells the full story. See the STU:IC7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
80GF Score
Get the complete analysis for STU:IC7
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:IC7 has been successfully added to your 
